BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Treatment
240 results:

  • 1. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
    Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
    J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Peritumor Mucosa in Advanced Laryngeal Carcinoma Exhibits an Aberrant Proangiogenic Signature Distinctive from the Expression Pattern in Adjacent Tumor Tissue.
    Kyurkchiyan SG; Stancheva G; Petkova V; Panova S; Dobriyanova V; Stancheva I; Marinov V; Zahariev Z; Kaneva RP; Popov TM
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607072
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
    Weber M; Ries J; Braun K; Wehrhan F; Distel L; Geppert C; Lutz R; Kesting M; Trumet L
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474362
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. PHA-665752's Antigrowth and Proapoptotic Effects on HSC-3 Human Oral cancer Cells.
    Yadav AK; Wang S; Shin YM; Jang BC
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474118
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anlotinib suppressed tumor cell proliferation and migration in hypopharyngeal carcinoma.
    Song H; Song Q; Zhao X; Yang Y; Mou Y; Li Y; Song X
    Braz J Otorhinolaryngol; 2024; 90(2):101397. PubMed ID: 38330738
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Exploring the therapeutic potential of curcumin in oral squamous cell carcinoma (HSC-3 cells): Molecular insights into hypoxia-mediated angiogenesis.
    Jayaraman S; Veeraraghavan VP; Natarajan SR; Jasmine S
    Pathol Res Pract; 2024 Feb; 254():155130. PubMed ID: 38277750
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. THBS1 promotes angiogenesis and accelerates ESCC malignant progression by the HIF-1/VEGF signaling pathway.
    Zhou X; Xia Q; Chen M; Zhang X; Huang M; Zheng X; Wang S; Wu B; Du Z
    Cell Biol Int; 2024 Mar; 48(3):311-324. PubMed ID: 38233982
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cold atmospheric plasma sensitizes head and neck cancer to chemotherapy and immune checkpoint blockade therapy.
    Wang Y; Mang X; Li D; Wang Z; Chen Y; Cai Z; Tan F
    Redox Biol; 2024 Feb; 69():102991. PubMed ID: 38103343
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Asiaticoside Down-Regulates HIF-1α to Inhibit Proliferation, Migration, and Angiogenesis in Thyroid cancer Cells.
    Zhang Y; Han Y; Dong J; Li F; Sun Y
    Balkan Med J; 2024 Jan; 41(1):23-29. PubMed ID: 38044598
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Hypoxia-induced factor-1α promotes radioresistance of esophageal cancer cells by transcriptionally activating LINC01116 and suppressing miR-3612 under hypoxia.
    Zhang M; Wang Z; Wu Y; Chen M; Li J; Liu G
    J Biochem Mol Toxicol; 2024 Jan; 38(1):e23551. PubMed ID: 37983895
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. HIF-1α regulates the cell viability in radioiodine-resistant papillary thyroid carcinoma cells induced by hypoxia through PKM2/NF-κB signaling pathway.
    Wang D; Liu X; Li M; Ning J
    Mol Carcinog; 2024 Feb; 63(2):238-252. PubMed ID: 37861358
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Hypoxia-induced TMTC3 expression in esophageal squamous cell carcinoma potentiates tumor angiogenesis through Rho GTPase/STAT3/VEGFA pathway.
    Yuan H; Zhao Z; Xu J; Zhang R; Ma L; Han J; Zhao W; Guo M; Song Y
    J Exp Clin Cancer Res; 2023 Sep; 42(1):249. PubMed ID: 37752569
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Estrogen receptor β affects hypoxia response in colorectal cancer cells.
    Rawłuszko-Wieczorek AA; Lipowicz J; Nowacka M; Ostrowska K; Pietras P; Blatkiewicz M; Ruciński M; Jagodziński PP; Nowicki M
    Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166894. PubMed ID: 37748565
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Using network pharmacological analysis and molecular docking to investigate the mechanism of action of quercetin's suppression of oral cancer.
    Dong H; Li M; Chen H; Tian L; Wei W; Wang S; Cheng G; Liu S
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15055-15067. PubMed ID: 37610675
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Antrodia salmonea suppresses epithelial-mesenchymal transition/metastasis and Warburg effects by inhibiting Twist and HIF-1α expression in Twist-overexpressing head and neck squamous cell carcinoma cells.
    Hseu JH; Lin YA; Pandey S; Vadivalagan C; Ali A; Chen SJ; Way TD; Yang HL; Hseu YC
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117030. PubMed ID: 37572931
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance.
    Trocchianesi S; Po A; Citarella A; Spinello Z; Rughetti A; Besharat ZM; Autilio TM; Pecce V; Verrienti A; Elisei R; Durante C; Catanzaro G; Ferretti E
    Biomed Pharmacother; 2023 Aug; 164():114995. PubMed ID: 37301138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.
    Wang J; Liu Y; Zhang Y; Li X; Fang M; Qian D
    Cancer Med; 2023 Jun; 12(11):12608-12621. PubMed ID: 37097161
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The relation between hypoxia and proliferation biomarkers with radiosensitivity in locally advanced laryngeal cancer.
    van den Bovenkamp K; van der Vegt B; Halmos GB; Slagter-Menkema L; Langendijk JA; van Dijk BAC; Schuuring E; van der Laan BFAM
    Eur Arch Otorhinolaryngol; 2023 Aug; 280(8):3801-3809. PubMed ID: 37029804
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.
    Li PJ; Lai SZ; Jin T; Ying HJ; Chen YM; Zhang P; Hang QQ; Deng H; Wang L; Feng JG; Chen XZ; Guo P; Chen M; Tian Y; Chen YY
    Radiother Oncol; 2023 Jun; 183():109633. PubMed ID: 36963438
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.